OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
High-dose, short-duration versus standard rifampicin for tuberculosis preventive treatment: a partially blinded, three-arm, non-inferiority, randomised, controlled trial
Rovina Ruslami, Federica Fregonese, Lika Apriani, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 6, pp. 433-443
Closed Access | Times Cited: 5
Rovina Ruslami, Federica Fregonese, Lika Apriani, et al.
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 6, pp. 433-443
Closed Access | Times Cited: 5
Showing 5 citing articles:
Safety of Triple-Dose Rifampin in Tuberculosis Treatment: A Systematic Review and Meta-Analysis
Omri Avraham Arbiv, Thomas W. Holmes, Marie JeongMin Kim, et al.
Clinical Infectious Diseases (2025)
Closed Access
Omri Avraham Arbiv, Thomas W. Holmes, Marie JeongMin Kim, et al.
Clinical Infectious Diseases (2025)
Closed Access
A Year in Review on Tuberculosis and Non-tuberculous Mycobacteria Disease: A 2025 Update for Clinicians and Scientists
Christoph Lange, Graham Bothamley, Gunar Günther, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 2, pp. 1-45
Open Access
Christoph Lange, Graham Bothamley, Gunar Günther, et al.
Pathogens and Immunity (2025) Vol. 10, Iss. 2, pp. 1-45
Open Access
Mn2O@Zn-N nanocarbon based on pyrolytically ZIF-8-on-MnO2 as high-performance electrochemical sensor for ultrasensitive detection of rifampicin in environmental samples
Di Wu, Yilin Wang, Zhifang Liu, et al.
Journal of environmental chemical engineering (2025), pp. 116372-116372
Closed Access
Di Wu, Yilin Wang, Zhifang Liu, et al.
Journal of environmental chemical engineering (2025), pp. 116372-116372
Closed Access
Efficacy and safety of 8-week regimens for the treatment of rifampicin-susceptible pulmonary tuberculosis (TRUNCATE-TB): a prespecified exploratory analysis of a multi-arm, multi-stage, open-label, randomised controlled trial
Nicholas I. Paton, C S G Cousins, Intan Permata Sari, et al.
The Lancet Infectious Diseases (2025)
Open Access
Nicholas I. Paton, C S G Cousins, Intan Permata Sari, et al.
The Lancet Infectious Diseases (2025)
Open Access
High-dose rifampicin to treat tuberculosis infection: potential and pitfalls
Theresa Ryckman, Nicole Salazar‐Austin
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 6, pp. 420-421
Closed Access
Theresa Ryckman, Nicole Salazar‐Austin
The Lancet Respiratory Medicine (2024) Vol. 12, Iss. 6, pp. 420-421
Closed Access
Pharmacokinetics of standard versus high-dose rifampin for tuberculosis preventive treatment: A sub-study of the 2R2 randomized controlled trial
Fajri Gafar, Vycke Yunivita, Federica Fregonese, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107197-107197
Open Access
Fajri Gafar, Vycke Yunivita, Federica Fregonese, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 1, pp. 107197-107197
Open Access
